Amy C. Porter
Impact in
- Pharmacology top 0.5%
- Cannabis and Cannabinoid Research
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
Papers in
-
- Receptor Mechanisms and Signaling 8
- RNA regulation and disease 3
- Pharmacology 10
- Cannabis and Cannabinoid Research 7
- Co-authors
- Richard R. Vaillancourt (3 shared papers)Christian C. Felder (6 shared papers)Ruchira Sood (3 shared papers)Ronald C. Wek (3 shared papers)John‐Michael Sauer (8 shared papers)Frank P. Bymaster (2 shared papers)Douglas R. Cavener (1 shared paper)Gary R. Fanger (2 shared papers)
- Journals
- Journal of Pharmacology and Experimental Therapeutics (2 papers)Biochemical Journal (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Experimental Biology and Medicine (2 papers)Life Sciences (2 papers)
- Partner nations
- United StatesCanada
In The Last Decade
Amy C. Porter
33 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 109
- Pharmacology 939
- Cellular and Molecular Neuroscience 677
- Toxicology 116
- Cell Biology 338
- Endocrine and Autonomic Systems 114
Countries citing papers authored by Amy C. Porter
This map shows the geographic impact of Amy C. Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy C. Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy C. Porter more than expected).
Fields of papers citing papers by Amy C. Porter
This network shows the impact of papers produced by Amy C. Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy C. Porter. The network helps show where Amy C. Porter may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy C. Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 441 | |
| 2 | 1998 | 264 | |
| 3 | 2000 | 232 | |
| 4 | 2001 | 189 | |
| 5 | 1998 | 133 | |
| 6 | 2000 | 124 | |
| 7 | 2004 | 110 | |
| 8 | 2001 | 97 | |
| 9 | 2000 | 96 | |
| 10 | 1994 | 90 | |
| 11 | 2001 | 80 | |
| 12 | 2002 | 71 | |
| 13 | 1999 | 69 | |
| 14 | 2005 | 58 | |
| 15 | 2020 | 44 | |
| 16 | 2011 | 43 | |
| 17 | 2011 | 38 | |
| 18 | 2013 | 33 | |
| 19 | 2012 | 21 | |
| 20 | 1996 | 20 |
About Amy C. Porter
Amy C. Porter is a scholar working on Molecular Biology, Pharmacology, Physiology, Cellular and Molecular Neuroscience and Economics and Econometrics, having authored 35 papers that have together received 2.3k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (8 papers), Cannabis and Cannabinoid Research (7 papers), Neuroscience and Neuropharmacology Research (4 papers), Biomedical Ethics and Regulation (4 papers), RNA regulation and disease (3 papers), Forensic Toxicology and Drug Analysis (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Pancreatic function and diabetes (3 papers). The work is most often cited by research in Pharmacology (939 citations), Cellular and Molecular Neuroscience (677 citations), Toxicology (116 citations), Cell Biology (338 citations) and Endocrine and Autonomic Systems (114 citations). Amy C. Porter has collaborated with scholars based in United States and Canada. Frequent co-authors include Richard R. Vaillancourt, Christian C. Felder, Ruchira Sood, Ronald C. Wek, John‐Michael Sauer, Frank P. Bymaster, Douglas R. Cavener, Gary R. Fanger, Kun Ma and Lawrence A. Quilliam. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Biochemical Journal, Bioorganic & Medicinal Chemistry Letters, Experimental Biology and Medicine and Life Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.